Night Vision Disturbances
Night Vision Disturbances Market

Night Vision Disturbances (NVD) is a decrease in the quality of vision secondary to glare disability, with decreased contrast sensitivity and consequential image degradation.


Common symptoms of Night Vision Disturbances are glare, hallos, starburst, ghosting, image degradation, contrast sensitivity.


Night Vision Disturbances Epidemiological Segmentation  


  • Total Night Vision Disturbances incident cases
  • Incident cases of Night Vision Disturbances by type of surgeries
  • Incidence of Night Vision Disturbances manifestations


Night Vision Disturbances Epidemiological Insights Observed in 2020


  • The total 7MM incident cases of Night Vision Disturbances were 3,128,058.
  • In the United States, Night Vision Disturbances cases of Glare cases, Halos cases, and Other manifestations are observed to be 567,732, 655,196, and 338,921 cases.
  • The number of incident cases of Night Vision Disturbances in the United States was 1,561,849.
  • The number of incident cases of Night Vision Disturbances in France where 264,659
  • The number of incident cases of Night Vision Disturbances in Spain was 180,877
  • The number of incident cases of Night Vision Disturbances in Japan was 479,695


Night Vision Disturbances Market Insight


The market size of Night Vision Disturbances in the 7MM was found to be USD 282.6 million in 2020.  


Night Vision Disturbances Market Drivers


  • Market share potential
  • Rising incidence
  • Increased awareness


Night Vision Disturbances Market Barriers


  • Poor pipeline
  • Insufficient literature
  • Challenges in treatment


Night Vision Disturbances Emerging Drugs


The key players working in the Night Vision Disturbances market are


  • Nyxol, and several others.


Night Vision Disturbances Key Players 


The key players working in the Night Vision Disturbances market are


  • Ocuphire Pharma, and several others.